4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-22-103166
Chief Dev. & Ops. Officer bought 220 shares at $7.87 ($1,731)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shemesh Shay Chief Dev. & Ops. Officer | 2022-09-23 | Purchase | +220 | $7.87 | $1,731 | 1,245,065 | D |
| Open-market purchases · 220 sh · avg $7.87 · $1,731 | |||||||
Loading xslF345X03/tm2226689-2_4seq1.xml…